Group 1: Company Performance and Future Plans - The company aims to enhance its operational level and profitability while maintaining stable performance to reward shareholders [1] - As of the end of Q3 2025, the company holds 12,930,660 shares of Jiangsu Bank, with plans to sell remaining shares based on market conditions and operational needs [1] - The company is currently assessing its technological capabilities and conducting market research to advance its robotics project [1] Group 2: Financing and Market Management - The company will consider its operational development, long-term strategy, and external financing environment when planning capital operations, ensuring timely information disclosure for any related plans [2] - The company emphasizes value management through stable cash dividends, effective investor relations, and enhanced transparency in information disclosure to create long-term value for investors [2]

采写 | 南都·湾财社记者 张海霞 本文自南都·湾财社。 其中，贵州茅台2025年中期分红方案为：每股派发现金红利23.957元（含税），总股本12.52亿股，共计派发现金红利300.01亿元（含税）。五粮液中期利 润分配方案为：以公司总股本38.82亿股为基数，向全体股东每10股派25.78元现金（含税），合计100.07亿元（含税）。 有行业人士分析认为，头部白酒企业高分红是其稳健的财务状况、积极回馈投资者、投资价值的体现，也应注意到高分红仅是上市公司的单一指标，投资 者需要结合多维度综合考虑投资价值。 来源于五粮液《股东回报规划》 据南都湾财社记者统计，贵州茅台2024年中期分红300亿元、2024年年度分红346.71亿元，合计超600亿元，占茅台2024年净利润862.3亿元的比例为75%； 五粮液2024年中期分红100亿元（含税）叠加2024年度分红123.01亿元（含税），合计223.01亿元，占公司2024年度净利润的比例为70.02%。 | 股份类别 | 股权登记日 | 最后交易日 除权（息）日 现金红利发放日 | | | | --- | --- | --- | --- | --- | | ...

Core Viewpoint - The company held a Q3 2025 earnings presentation to address investor concerns and outline strategies for improving profitability and operational efficiency [1] Group 1: Earnings Presentation Overview - The earnings presentation was conducted online on December 10, 2025, with participation from key executives including the chairman and financial director [1] - The company emphasized its commitment to investor communication and transparency during the presentation [1] Group 2: Cost Control and Profitability Measures - The company is implementing several measures to enhance profitability, including refined operations, cost reduction strategies, and increased operational efficiency [2] - Specific actions include promoting energy-saving technologies and enhancing digital transformation to improve operational capabilities [2] Group 3: Technological Innovation and Industry Upgrades - The company is focusing on technological innovation to support high-quality development and green industry transformation [3] - Efforts include building a skilled research team and integrating digital management with business operations [3] Group 4: Market Value Management and Shareholder Returns - The company acknowledges the decline in stock price and emphasizes its commitment to market value management and enhancing shareholder returns [3] - Future strategies include improving operational performance and maintaining effective communication with investors to foster a better understanding of the company's value [5] Group 5: Fly Ash Technology Development - The company is advancing the "fly ash low-carbon collaborative reduction and harmless treatment process" in partnership with Tongji University, contributing to waste management initiatives [5]

Core Viewpoint - The company is facing significant investor dissatisfaction regarding its declining stock price and performance, with investors expressing concerns about management's effectiveness and the company's future prospects [2][3]. Group 1: Stock Price Concerns - Investors raised multiple questions about the company's stock price during the recent earnings call, with six out of twelve questions focusing on this issue [2]. - The company's market capitalization peaked at over 66 billion yuan in September 2020 but has since fallen to approximately 13.5 billion yuan by December 3, 2025 [2]. - Investors criticized the delay in the major shareholder's planned stock buyback of up to 400 million yuan, suggesting it misleads investors about potential performance risks [2]. Group 2: Financial Performance - Over the past five years, the company's revenue has fluctuated between 5.1 billion yuan and 5.6 billion yuan, with net profit generally positive except for a loss in 2022 [3]. - For the first three quarters of 2025, the company reported revenue of approximately 3.156 billion yuan, a year-on-year decline of 20.01%, and a net profit of about 380 million yuan, down 34.07% year-on-year [6]. - The company is implementing measures to improve performance, including optimizing product structure, enhancing operational efficiency, and expanding sales channels [6]. Group 3: Strategic Plans and Acquisitions - The company is cautiously balancing its cash position with potential acquisition opportunities, with several projects currently in progress [7]. - There is no confirmed partnership with China Resources, despite previous interest from other strategic partners [7]. - The company emphasizes the importance of maintaining operational capability post-acquisition and avoiding risks associated with reckless expansion [7].

Core Viewpoint - The company is facing significant investor dissatisfaction regarding its declining stock price and performance, with investors expressing concerns about management's effectiveness and the company's future prospects [1][2]. Group 1: Stock Performance and Investor Sentiment - Investors have raised multiple questions about the company's stock price, with six out of twelve questions specifically addressing this issue, indicating strong dissatisfaction with the stock's downward trend [1]. - The company's market capitalization peaked at over 66 billion yuan in September 2020 but has since fallen to approximately 13.5 billion yuan by December 3, 2025 [1]. - The largest shareholder plans to increase their stake in the company by investing between 200 million and 400 million yuan, starting from September 1, 2025 [2]. Group 2: Financial Performance - Over the past five years (2020-2024), the company's revenue has fluctuated between 5.1 billion and 5.6 billion yuan, with net profit generally positive except for a loss in 2022 [3]. - For the first three quarters of 2025, the company reported revenue of approximately 3.156 billion yuan, a year-on-year decline of 20.01%, and a net profit of about 380 million yuan, down 34.07% year-on-year [6]. - The company is implementing measures to improve performance, including optimizing product structure, enhancing operational efficiency, and expanding sales channels [6]. Group 3: Strategic Plans and Mergers - The company is cautiously balancing its cash position with potential acquisition opportunities, with several projects currently in progress, although no agreements on transaction prices have been reached [7]. - There have been inquiries about potential mergers, but the company emphasizes the importance of sustainable operations post-acquisition and is avoiding reckless expansion that could harm performance [7]. - The company has not engaged in deep discussions with any strategic partners, including rumors regarding cooperation with China Resources [7].

12月10日晚间，贵州茅台（600519.SH）、五粮液（000858.SZ）相继发布中期分红公告，将分别于12月 19日、12月18日派发中期分红，两大白酒巨头合计派发中期红利约400亿元。 其中，贵州茅台2025年中期分红方案为：每股派发现金红利23.957元（含税），总股本12.52亿股，共计 派发现金红利300.01亿元（含税）。五粮液中期利润分配方案为：以公司总股本38.82亿股为基数，向全 体股东每10股派25.78元现金（含税），合计100.07亿元（含税）。 有行业人士分析认为，头部白酒企业高分红是其稳健的财务状况、积极回馈投资者、投资价值的体现， 也应注意到高分红仅是上市公司的单一指标，投资者需要结合多维度综合考虑投资价值。 南都湾财社记者注意到，贵州茅台、五粮液之外，泸州老窖（000568.SZ）、洋河股份（002304.SZ）、 山西汾酒（600809.SH）等白酒上市公司都纷纷启动了中期分红，不少白酒上市公司发布《市值管理制 度》，明确"现金分红"是市值管理的主要方式之一。 以五粮液为例，今年3月份，公司发布《市值管理制度》表示，公司应当聚焦主业，提升经营效率和盈 利能力，同时可以结合 ...

证券日报网12月10日讯中科曙光（603019）在回答调研者提问时表示，目前公司生产经营情况正常，本 次交易终止不会对公司的生产经营和财务状况造成重大不利影响。公司将从以下方面进行市值管理，维 护广大投资人的利益：(1)公司将立足目前的业务，持续巩固并扩大在产业链上的核心竞争优势，立足 价值创造，做好做优主营业务。(2)公司已披露中期分红议案，并在12月召开股东会审议后实施，以实 际行动回报广大投资人。(3)后续公司将以更谨慎的制度建设，更透明的信息披露，更主动的投资者沟 通维护中小股东的利益。 ...

Core Viewpoint - The article discusses the strategic market operations of Haixi New Drug (02637) over the past two months, highlighting a well-planned effort to increase market capitalization and liquidity in preparation for inclusion in the Hong Kong Stock Connect program [1][3]. Group 1: Market Operation Phases - The market operation can be divided into four distinct phases aimed at enhancing and stabilizing market capitalization to meet the Hong Kong Stock Connect inclusion criteria [3]. Phase 1: Accumulation - From October 20 to October 30, the stock price rose from 97.50, increasing by 18.63% over eight trading days, with a significant trading volume of 379.17 million and a turnover rate of 4.82% [4][5]. - The bullish trading volume accounted for 87.5%, indicating strong buying power and establishing a solid foundation for future operations [4]. Phase 2: Technical Adjustment - From October 31 to November 5, the stock experienced a technical adjustment with a price decline of 5.79% and a drastic drop in trading volume to 47.87 million, reflecting a controlled "volume reduction" strategy to clear short-term floating positions [5][6]. Phase 3: Breakthrough - From November 6 to November 12, the stock surged from 112.50 to 147.00, marking a 26.49% increase with a low turnover rate of 0.79%, indicating a high level of control by the main operators [7][8]. Phase 4: Consolidation - From November 13 to December 9, the stock price stabilized around 130.54, showing strong support with more bullish days than bearish ones, preparing for further market consensus and potential value expansion [9][10]. Group 2: Market Capitalization Strategy - Haixi New Drug has submitted an application for "full circulation" of shares, which will allow major shareholders to trade their shares in the secondary market after a 12-month lock-up period, enhancing the motivation for active market capitalization management [12]. - The company aims to exceed the core requirement of a daily average market capitalization of 93 billion HKD to qualify for the Hong Kong Stock Connect, achieving a market cap of 97.7 billion HKD as of December 10 [12][13]. - The strategy is designed to secure a "market capitalization safety cushion" by significantly increasing the market cap early in the assessment period, thus reducing the risk of falling below the required threshold [12][13].

Core Viewpoint - The article discusses the strategic market operations of Haixi New Drug (02637) over the past two months, highlighting a well-planned effort to increase market capitalization and liquidity in preparation for inclusion in the Hong Kong Stock Connect program [1][11]. Group 1: Market Operation Phases - The market operation can be divided into four distinct phases aimed at enhancing and stabilizing market capitalization to meet the Hong Kong Stock Connect inclusion criteria [3][11]. Phase 1: Accumulation - From October 20 to October 30, the stock price rose from 97.50, increasing by 18.63% over eight trading days, with a significant trading volume of 379.17 million shares and a turnover rate of 4.82% [3][4]. - The buying pressure was dominant, with 87.5% of the trading volume being positive, indicating strong accumulation by the main players [3][4]. Phase 2: Technical Adjustment - From October 31 to November 5, the stock experienced a 5.79% pullback with a drastic reduction in trading volume to 47.87 million shares and a turnover rate of only 0.61% [5][6]. - This phase was characterized by a "volume contraction" strategy to clear short-term floating positions and raise the average market holding cost [5]. Phase 3: Breakthrough - From November 6 to November 12, the stock surged from 112.50 to 147.00, marking a 26.49% increase with a low turnover rate of 0.79% and 100% of the trading volume being positive [7][8]. - This indicates a high level of control by the main players, allowing for a rapid price increase with minimal capital outlay [7]. Phase 4: Consolidation - From November 13 to December 9, the stock underwent a period of consolidation around a new price level, maintaining an average price of 130.54, with more positive trading days than negative [9][10]. - This consolidation phase is crucial for building market consensus and preparing for further market capitalization expansion [9]. Group 2: Market Capitalization Strategy - Haixi New Drug has submitted an application for "full circulation" of shares, which will allow major shareholders to sell their shares in the secondary market after a 12-month lock-up period, enhancing the motivation for active market capitalization management [12]. - The company aims to exceed the minimum daily market capitalization requirement of 9.3 billion HKD to qualify for the Hong Kong Stock Connect program, with a current average market capitalization of 9.77 billion HKD as of December 10 [12][13]. - The strategy is designed to secure a "market capitalization safety cushion" by significantly increasing market value at the beginning of the assessment period, thus reducing the risk of falling below the required threshold [12][13].

Group 1: Business Outlook - The company aims to leverage its product mix advantages to penetrate various niche markets, including data centers, communications, oil and gas fields, and high-end manufacturing [2][3] - In the data center sector, the company plans to capitalize on its generator products' superior performance metrics, brand influence, market layout, and service network to expand its market share and impact [2] Group 2: Future Development of Changbo Company - Changbo Company is currently facing operational losses due to fluctuations in public vessel order demand and its wholly-owned subsidiary, Bo Xing Company, not yet realizing performance release [2][3] - The company recognizes Changbo's significant market potential and competitive advantages, including abundant business resources, well-established infrastructure, favorable geographic location, and product differentiation [3] - The strategy involves leveraging Changbo's competitive strengths through upstream and downstream industry chain collaboration to promote performance growth and achieve synergistic benefits [3] Group 3: Dividend and Shareholder Return Plans - The company places high importance on shareholder returns and actively responds to policy calls, planning to implement cash dividends twice a year based on comprehensive considerations of operational performance, financial status, market demands, and future development plans [3] - Future strategies will focus on "seeking progress while maintaining stability," emphasizing high-quality development and continuous profit improvement, while effectively utilizing various market value management tools to create greater value for investors [3]